Personalized Medicine Target opportunities around patient-derived tumor models and personalized oncology drug testing using SynVivo's microfluidic chips to simulate tumor microenvironments and assess drug efficacy for individualized treatment strategies.

Early-Stage Collaboration Position SynVivo as a partner for co-development of organ-on-chip platforms with pharma and biotech companies seeking to accelerate preclinical studies, disease modeling, and compound screening in realistic vascular environments.

Clinical-Grade Visualization Leverage real-time visualization and quantitation capabilities to offer contract research or custom assay development services that provide actionable readouts on cellular behavior, drug delivery, and hemodynamic responses.

Niche Market Position Emphasize the unique microvasculature and hemodynamics modeling to differentiate from larger competitors, targeting mid-sized biotech firms and academic collaborations focused on cancer, vascular biology, and tissue engineering.

Growth Readiness Highlight potential for scale and integration with existing workflows and data ecosystems (e.g., HubSpot, CRM and marketing tools) to support partnerships, grant opportunities, and multi-institution collaborations as the company grows.